Cargando…
Insurance Delays in Initiation of Tumor Necrosis Factor Inhibitors in Children With Juvenile Idiopathic Arthritis
This cohort study compares the delays in tumor necrosis factor inhibitor (TNFi) initiation because of insurance among children enrolled in public and private insurance plans.
Autores principales: | Roberts, Jordan E., Fan, Mary, Son, Mary Beth F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024383/ https://www.ncbi.nlm.nih.gov/pubmed/35446398 http://dx.doi.org/10.1001/jamanetworkopen.2022.8330 |
Ejemplares similares
-
Cyclophosphamide therapy for secondary amyloidosis in a patient with juvenile idiopathic arthritis unresponsive to tumor necrosis factor α inhibitor therapy
por: Han, Sun Ae, et al.
Publicado: (2016) -
Tumor necrosis factor-alpha polymorphism and susceptibility to juvenile idiopathic arthritis
por: Bayraktar, S, et al.
Publicado: (2008) -
Screening for celiac disease in juvenile idiopathic arthritis
por: Poddighe, Dimitri
Publicado: (2022) -
Fucosidosis mimicking juvenile idiopathic arthritis
por: Wynne, Emma, et al.
Publicado: (2018) -
RE: Oligoarticular juvenile idiopathic arthritis among Saudi children
por: Al-Mendalawi, Mahmood D.
Publicado: (2014)